| 000 | 01222 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516042225.0 | ||
| 264 | 0 | _c20111020 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1662-2782 | ||
| 024 | 7 |
_a10.1159/000325671 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMathew, Anna | |
| 245 | 0 | 0 |
_aAntifibrotic treatment and other new strategies for improving renal outcomes. _h[electronic resource] |
| 260 |
_bContributions to nephrology _c2011 |
||
| 300 |
_a217-227 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aConnective Tissue Growth Factor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
| 650 | 0 | 4 |
_aFibrosis _xprevention & control |
| 650 | 0 | 4 |
_aGlycation End Products, Advanced _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xpathology |
| 650 | 0 | 4 |
_aRenin-Angiotensin System _xphysiology |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xantagonists & inhibitors |
| 700 | 1 | _aCunard, Robyn | |
| 700 | 1 | _aSharma, Kumar | |
| 773 | 0 |
_tContributions to nephrology _gvol. 170 _gp. 217-227 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000325671 _zAvailable from publisher's website |
| 999 |
_c20915882 _d20915882 |
||